 | • レポートコード：QYR2104Z2787 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、C型肝炎ウイルス（HCV）用抗ウイルス剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HCV抗体、HCVウイルス量、HCVジェノタイピング）、用途別市場規模（診断センター、病院、家庭用）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・C型肝炎ウイルス（HCV）用抗ウイルス剤の市場動向 ・企業の競争状況、市場シェア ・C型肝炎ウイルス（HCV）用抗ウイルス剤の種類別市場規模（HCV抗体、HCVウイルス量、HCVジェノタイピング） ・C型肝炎ウイルス（HCV）用抗ウイルス剤の用途別市場規模（診断センター、病院、家庭用） ・C型肝炎ウイルス（HCV）用抗ウイルス剤の北米市場規模2016-2027（アメリカ、カナダ） ・C型肝炎ウイルス（HCV）用抗ウイルス剤のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・C型肝炎ウイルス（HCV）用抗ウイルス剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・C型肝炎ウイルス（HCV）用抗ウイルス剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・C型肝炎ウイルス（HCV）用抗ウイルス剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche Diagnostics、Abbott、Siemens、Qiagen、bioMérieux、Bio-Rad Laboratories、Meridian Bioscience、Vista Diagnostics、Biogate Laboratories、J.Mitra & Co. Ltd、Siemens Medical、General Biologicals） ・結論 |
Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests. According to World Health Organization (WHO), globally 130 million to 150 million people are suffering from chronic hepatitis C. Hepatitis C is treated with antiviral drugs to inhibit the growth of virus and prevent liver damage. According to World Health Organization (WHO), 50% to 90% of people suffering from hepatitis C are treated with antiviral treatment.
Market Analysis and Insights: Global Hepatitis C Virus (HCV) Antiviral Market
The global Hepatitis C Virus (HCV) Antiviral market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hepatitis C Virus (HCV) Antiviral market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hepatitis C Virus (HCV) Antiviral market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hepatitis C Virus (HCV) Antiviral market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hepatitis C Virus (HCV) Antiviral market.
Global Hepatitis C Virus (HCV) Antiviral Scope and Market Size
Hepatitis C Virus (HCV) Antiviral market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis C Virus (HCV) Antiviral market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
HCV Antibody
HCV Viral Load
HCV Genotyping
Segment by Application
Diagnostic Centers
Hospitals
Home Use
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche Diagnostics
Abbott
Siemens
Qiagen
bioMérieux
Bio-Rad Laboratories
Meridian Bioscience
Vista Diagnostics
Biogate Laboratories
Qiagen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 HCV Antibody
1.2.3 HCV Viral Load
1.2.4 HCV Genotyping
1.3 Market by Application
1.3.1 Global Hepatitis C Virus (HCV) Antiviral Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic Centers
1.3.3 Hospitals
1.3.4 Home Use
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis C Virus (HCV) Antiviral Market Perspective (2016-2027)
2.2 Hepatitis C Virus (HCV) Antiviral Growth Trends by Regions
2.2.1 Hepatitis C Virus (HCV) Antiviral Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hepatitis C Virus (HCV) Antiviral Historic Market Share by Regions (2016-2021)
2.2.3 Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Regions (2022-2027)
2.3 Hepatitis C Virus (HCV) Antiviral Industry Dynamic
2.3.1 Hepatitis C Virus (HCV) Antiviral Market Trends
2.3.2 Hepatitis C Virus (HCV) Antiviral Market Drivers
2.3.3 Hepatitis C Virus (HCV) Antiviral Market Challenges
2.3.4 Hepatitis C Virus (HCV) Antiviral Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis C Virus (HCV) Antiviral Players by Revenue
3.1.1 Global Top Hepatitis C Virus (HCV) Antiviral Players by Revenue (2016-2021)
3.1.2 Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Players (2016-2021)
3.2 Global Hepatitis C Virus (HCV) Antiviral Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hepatitis C Virus (HCV) Antiviral Revenue
3.4 Global Hepatitis C Virus (HCV) Antiviral Market Concentration Ratio
3.4.1 Global Hepatitis C Virus (HCV) Antiviral Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Virus (HCV) Antiviral Revenue in 2020
3.5 Hepatitis C Virus (HCV) Antiviral Key Players Head office and Area Served
3.6 Key Players Hepatitis C Virus (HCV) Antiviral Product Solution and Service
3.7 Date of Enter into Hepatitis C Virus (HCV) Antiviral Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis C Virus (HCV) Antiviral Breakdown Data by Type
4.1 Global Hepatitis C Virus (HCV) Antiviral Historic Market Size by Type (2016-2021)
4.2 Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Type (2022-2027)
5 Hepatitis C Virus (HCV) Antiviral Breakdown Data by Application
5.1 Global Hepatitis C Virus (HCV) Antiviral Historic Market Size by Application (2016-2021)
5.2 Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hepatitis C Virus (HCV) Antiviral Market Size (2016-2027)
6.2 North America Hepatitis C Virus (HCV) Antiviral Market Size by Type
6.2.1 North America Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021)
6.2.2 North America Hepatitis C Virus (HCV) Antiviral Market Size by Type (2022-2027)
6.2.3 North America Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2027)
6.3 North America Hepatitis C Virus (HCV) Antiviral Market Size by Application
6.3.1 North America Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2021)
6.3.2 North America Hepatitis C Virus (HCV) Antiviral Market Size by Application (2022-2027)
6.3.3 North America Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2027)
6.4 North America Hepatitis C Virus (HCV) Antiviral Market Size by Country
6.4.1 North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2016-2021)
6.4.2 North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Hepatitis C Virus (HCV) Antiviral Market Size (2016-2027)
7.2 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Type
7.2.1 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021)
7.2.2 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Type (2022-2027)
7.2.3 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2027)
7.3 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Application
7.3.1 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2021)
7.3.2 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Application (2022-2027)
7.3.3 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2027)
7.4 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country
7.4.1 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2016-2021)
7.4.2 Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size (2016-2027)
8.2 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Type
8.2.1 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2027)
8.3 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Application
8.3.1 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2027)
8.4 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Region
8.4.1 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hepatitis C Virus (HCV) Antiviral Market Size (2016-2027)
9.2 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Type
9.2.1 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021)
9.2.2 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Type (2022-2027)
9.2.3 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2027)
9.3 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Application
9.3.1 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2021)
9.3.2 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Application (2022-2027)
9.3.3 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2027)
9.4 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country
9.4.1 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2016-2021)
9.4.2 Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size (2016-2027)
10.2 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Type
10.2.1 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2027)
10.3 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Application
10.3.1 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2027)
10.4 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country
10.4.1 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Introduction
11.1.4 Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Hepatitis C Virus (HCV) Antiviral Introduction
11.2.4 Abbott Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens Hepatitis C Virus (HCV) Antiviral Introduction
11.3.4 Siemens Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
11.3.5 Siemens Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Details
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Hepatitis C Virus (HCV) Antiviral Introduction
11.4.4 Qiagen Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
11.4.5 Qiagen Recent Development
11.5 bioMérieux
11.5.1 bioMérieux Company Details
11.5.2 bioMérieux Business Overview
11.5.3 bioMérieux Hepatitis C Virus (HCV) Antiviral Introduction
11.5.4 bioMérieux Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
11.5.5 bioMérieux Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Introduction
11.6.4 Bio-Rad Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 Meridian Bioscience
11.7.1 Meridian Bioscience Company Details
11.7.2 Meridian Bioscience Business Overview
11.7.3 Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Introduction
11.7.4 Meridian Bioscience Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
11.7.5 Meridian Bioscience Recent Development
11.8 Vista Diagnostics
11.8.1 Vista Diagnostics Company Details
11.8.2 Vista Diagnostics Business Overview
11.8.3 Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Introduction
11.8.4 Vista Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
11.8.5 Vista Diagnostics Recent Development
11.9 Biogate Laboratories
11.9.1 Biogate Laboratories Company Details
11.9.2 Biogate Laboratories Business Overview
11.9.3 Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Introduction
11.9.4 Biogate Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
11.9.5 Biogate Laboratories Recent Development
11.10 J.Mitra & Co. Ltd
11.10.1 J.Mitra & Co. Ltd Company Details
11.10.2 J.Mitra & Co. Ltd Business Overview
11.10.3 J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Introduction
11.10.4 J.Mitra & Co. Ltd Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
11.10.5 J.Mitra & Co. Ltd Recent Development
11.11 Siemens Medical
11.11.1 Siemens Medical Company Details
11.11.2 Siemens Medical Business Overview
11.11.3 Siemens Medical Hepatitis C Virus (HCV) Antiviral Introduction
11.11.4 Siemens Medical Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
11.11.5 Siemens Medical Recent Development
11.12 General Biologicals
11.12.1 General Biologicals Company Details
11.12.2 General Biologicals Business Overview
11.12.3 General Biologicals Hepatitis C Virus (HCV) Antiviral Introduction
11.12.4 General Biologicals Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
11.12.5 General Biologicals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of HCV Antibody
Table 3. Key Players of HCV Viral Load
Table 4. Key Players of HCV Genotyping
Table 5. Global Hepatitis C Virus (HCV) Antiviral Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hepatitis C Virus (HCV) Antiviral Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hepatitis C Virus (HCV) Antiviral Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Hepatitis C Virus (HCV) Antiviral Market Share by Regions (2016-2021)
Table 9. Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Hepatitis C Virus (HCV) Antiviral Market Share by Regions (2022-2027)
Table 11. Hepatitis C Virus (HCV) Antiviral Market Trends
Table 12. Hepatitis C Virus (HCV) Antiviral Market Drivers
Table 13. Hepatitis C Virus (HCV) Antiviral Market Challenges
Table 14. Hepatitis C Virus (HCV) Antiviral Market Restraints
Table 15. Global Hepatitis C Virus (HCV) Antiviral Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Hepatitis C Virus (HCV) Antiviral Market Share by Players (2016-2021)
Table 17. Global Top Hepatitis C Virus (HCV) Antiviral Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Virus (HCV) Antiviral as of 2020)
Table 18. Ranking of Global Top Hepatitis C Virus (HCV) Antiviral Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Hepatitis C Virus (HCV) Antiviral Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hepatitis C Virus (HCV) Antiviral Product Solution and Service
Table 22. Date of Enter into Hepatitis C Virus (HCV) Antiviral Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Type (2016-2021)
Table 26. Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Hepatitis C Virus (HCV) Antiviral Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Application (2016-2021)
Table 30. Global Hepatitis C Virus (HCV) Antiviral Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Hepatitis C Virus (HCV) Antiviral Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Hepatitis C Virus (HCV) Antiviral Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Hepatitis C Virus (HCV) Antiviral Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Hepatitis C Virus (HCV) Antiviral Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size by Country (2022-2027) & (US$ Million)
Table 62. Roche Diagnostics Company Details
Table 63. Roche Diagnostics Business Overview
Table 64. Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Product
Table 65. Roche Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021) & (US$ Million)
Table 66. Roche Diagnostics Recent Development
Table 67. Abbott Company Details
Table 68. Abbott Business Overview
Table 69. Abbott Hepatitis C Virus (HCV) Antiviral Product
Table 70. Abbott Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021) & (US$ Million)
Table 71. Abbott Recent Development
Table 72. Siemens Company Details
Table 73. Siemens Business Overview
Table 74. Siemens Hepatitis C Virus (HCV) Antiviral Product
Table 75. Siemens Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021) & (US$ Million)
Table 76. Siemens Recent Development
Table 77. Qiagen Company Details
Table 78. Qiagen Business Overview
Table 79. Qiagen Hepatitis C Virus (HCV) Antiviral Product
Table 80. Qiagen Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021) & (US$ Million)
Table 81. Qiagen Recent Development
Table 82. bioMérieux Company Details
Table 83. bioMérieux Business Overview
Table 84. bioMérieux Hepatitis C Virus (HCV) Antiviral Product
Table 85. bioMérieux Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021) & (US$ Million)
Table 86. bioMérieux Recent Development
Table 87. Bio-Rad Laboratories Company Details
Table 88. Bio-Rad Laboratories Business Overview
Table 89. Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Product
Table 90. Bio-Rad Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021) & (US$ Million)
Table 91. Bio-Rad Laboratories Recent Development
Table 92. Meridian Bioscience Company Details
Table 93. Meridian Bioscience Business Overview
Table 94. Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Product
Table 95. Meridian Bioscience Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021) & (US$ Million)
Table 96. Meridian Bioscience Recent Development
Table 97. Vista Diagnostics Company Details
Table 98. Vista Diagnostics Business Overview
Table 99. Vista Diagnostics Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021) & (US$ Million)
Table 100. Vista Diagnostics Recent Development
Table 101. Biogate Laboratories Company Details
Table 102. Biogate Laboratories Business Overview
Table 103. Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Product
Table 104. Biogate Laboratories Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021) & (US$ Million)
Table 105. Biogate Laboratories Recent Development
Table 106. J.Mitra & Co. Ltd Company Details
Table 107. J.Mitra & Co. Ltd Business Overview
Table 108. J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Product
Table 109. J.Mitra & Co. Ltd Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021) & (US$ Million)
Table 110. J.Mitra & Co. Ltd Recent Development
Table 111. Siemens Medical Company Details
Table 112. Siemens Medical Business Overview
Table 113. Siemens Medical Hepatitis C Virus (HCV) Antiviral Product
Table 114. Siemens Medical Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021) & (US$ Million)
Table 115. Siemens Medical Recent Development
Table 116. General Biologicals Company Details
Table 117. General Biologicals Business Overview
Table 118. General Biologicals Hepatitis C Virus (HCV) Antiviral Product
Table 119. General Biologicals Revenue in Hepatitis C Virus (HCV) Antiviral Business (2016-2021) & (US$ Million)
Table 120. General Biologicals Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis C Virus (HCV) Antiviral Market Share by Type: 2020 VS 2027
Figure 2. HCV Antibody Features
Figure 3. HCV Viral Load Features
Figure 4. HCV Genotyping Features
Figure 5. Global Hepatitis C Virus (HCV) Antiviral Market Share by Application: 2020 VS 2027
Figure 6. Diagnostic Centers Case Studies
Figure 7. Hospitals Case Studies
Figure 8. Home Use Case Studies
Figure 9. Hepatitis C Virus (HCV) Antiviral Report Years Considered
Figure 10. Global Hepatitis C Virus (HCV) Antiviral Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Hepatitis C Virus (HCV) Antiviral Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hepatitis C Virus (HCV) Antiviral Market Share by Regions: 2020 VS 2027
Figure 13. Global Hepatitis C Virus (HCV) Antiviral Market Share by Regions (2022-2027)
Figure 14. Global Hepatitis C Virus (HCV) Antiviral Market Share by Players in 2020
Figure 15. Global Top Hepatitis C Virus (HCV) Antiviral Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Virus (HCV) Antiviral as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Hepatitis C Virus (HCV) Antiviral Revenue in 2020
Figure 17. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Type (2016-2021)
Figure 18. Global Hepatitis C Virus (HCV) Antiviral Revenue Market Share by Type (2022-2027)
Figure 19. North America Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Hepatitis C Virus (HCV) Antiviral Market Share by Type (2016-2027)
Figure 21. North America Hepatitis C Virus (HCV) Antiviral Market Share by Application (2016-2027)
Figure 22. North America Hepatitis C Virus (HCV) Antiviral Market Share by Country (2016-2027)
Figure 23. United States Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hepatitis C Virus (HCV) Antiviral Market Share by Type (2016-2027)
Figure 27. Europe Hepatitis C Virus (HCV) Antiviral Market Share by Application (2016-2027)
Figure 28. Europe Hepatitis C Virus (HCV) Antiviral Market Share by Country (2016-2027)
Figure 29. Germany Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Share by Region (2016-2027)
Figure 39. China Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hepatitis C Virus (HCV) Antiviral Market Share by Type (2016-2027)
Figure 47. Latin America Hepatitis C Virus (HCV) Antiviral Market Share by Application (2016-2027)
Figure 48. Latin America Hepatitis C Virus (HCV) Antiviral Market Share by Country (2016-2027)
Figure 49. Mexico Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Hepatitis C Virus (HCV) Antiviral Market Share by Country (2016-2027)
Figure 55. Turkey Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Hepatitis C Virus (HCV) Antiviral Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Roche Diagnostics Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
Figure 59. Abbott Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
Figure 60. Siemens Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
Figure 61. Qiagen Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
Figure 62. bioMérieux Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
Figure 63. Bio-Rad Laboratories Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
Figure 64. Meridian Bioscience Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
Figure 65. Vista Diagnostics Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
Figure 66. Biogate Laboratories Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
Figure 67. J.Mitra & Co. Ltd Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
Figure 68. Siemens Medical Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
Figure 69. General Biologicals Revenue Growth Rate in Hepatitis C Virus (HCV) Antiviral Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界のC型肝炎ウイルス（HCV）検査市場規模・現状・予測（2021年-2027年） Hepatitis C Virus (HCV) Testing is the procedure to test if the patient have the Hepatitis C Virus. Market Analysis and Insights: Global Hepatitis C Virus (HCV) Testing Market The global Hepatitis C Virus (HCV) Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in …- 世界のC型肝炎ウイルス（HCV）市場規模・現状・予測（2021年-2027年） Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chro…
- 世界のB型肝炎ウイルス（HBV）市場規模・現状・予測（2021年-2027年） Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infectio…
- 世界の予防用B型肝炎ウイルスワクチン市場規模・現状・予測（2021年-2027年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…
- 世界のC型肝炎ウイルス検査市場規模・現状・予測（2021年-2027年） Hepatitis C virus (HCV) infection is detected with a blood test. Market Analysis and Insights: Global Hepatitis C Virus Testing Market The global Hepatitis C Virus Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With i…